Clinical, Ultrasonographic, and Laboratory Factors Associated With Endometrial Malignancy in Women With Postmenopausal Bleeding: A Retrospective Cohort Study

Background: Postmenopausal bleeding (PMB) requires evaluation for malignant pathology, but the discriminatory relevance of metabolic biomarkers and serum tumor markers remains uncertain. Objective: To examine clinical, ultrasonographic, and laboratory factors associated with malignant pathology among women undergoing histopathological evaluation for PMB. Methods: We retrospectively analyzed 876 women with classifiable pathology (688 non-malignant and 188 malignant). A prespecified multivariable logistic regression model included clinical characteristics, endometrial thickness, D-dimer, and tumor markers. Complete-case analysis included 728 patients, with multiple imputation performed as a sensitivity analysis. Natural cubic splines assessed nonlinear associations, and nested models evaluated the incremental discrimination provided by CA125 and CA19-9. Results: Women with malignant pathology were older and had greater endometrial thickness (both P < 0.001). In multivariable analysis, age (aOR 1.27 per 5 years, 95% CI 1.12–1.44), endometrial thickness (aOR 1.92 per 5 mm, 95% CI 1.60–2.31), CA125 (aOR 1.12 per 10 U/mL, 95% CI 1.04–1.21), and CA19-9 (aOR 1.16 per 10 U/mL, 95% CI 1.06–1.27) were associated with malignant pathology. Endometrial thickness showed evidence of nonlinearity (P = 0.030). Adding CA125 and CA19-9 to a model including age and endometrial thickness increased the apparent AUC from 0.744 to 0.781. BMI and conventional lipid-related measures showed limited discriminatory associations. Conclusions: Age, endometrial thickness, and selected tumor markers were associated with malignant pathology in this pathology-selected PMB cohort. The incremental discrimination provided by tumor markers was modest, and the findings require external validation before clinical application.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11413951/v1
Primary Topic
Endometrial and Cervical Cancer Treatments
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Clinical, Ultrasonographic, and Laboratory Factors Associated With Endometrial Malignancy in Women With Postmenopausal Bleeding: A Retrospective Cohort Study

M.S. Li, Xiaopei Zhou, yi shen, Boqun Xu et al.
2 links
Research Square
Endometrial and Cervical Cancer Treatments
preprint

Clinical, Ultrasonographic, and Laboratory Factors Associated With Endometrial Malignancy in Women With Postmenopausal Bleeding: A Retrospective Cohort Study

M.S. Li, Xiaopei Zhou, yi shen, Boqun Xu, Xiaoyan Li, Xiaokang Deng
preprint en

Abstract

Background: Postmenopausal bleeding (PMB) requires evaluation for malignant pathology, but the discriminatory relevance of metabolic biomarkers and serum tumor markers remains uncertain. Objective: To examine clinical, ultrasonographic, and laboratory factors associated with malignant pathology among women undergoing histopathological evaluation for PMB. Methods: We retrospectively analyzed 876 women with classifiable pathology (688 non-malignant and 188 malignant). A prespecified multivariable logistic regression model included clinical characteristics, endometrial thickness, D-dimer, and tumor markers. Complete-case analysis included 728 patients, with multiple imputation performed as a sensitivity analysis. Natural cubic splines assessed nonlinear associations, and nested models evaluated the incremental discrimination provided by CA125 and CA19-9. Results: Women with malignant pathology were older and had greater endometrial thickness (both P < 0.001). In multivariable analysis, age (aOR 1.27 per 5 years, 95% CI 1.12–1.44), endometrial thickness (aOR 1.92 per 5 mm, 95% CI 1.60–2.31), CA125 (aOR 1.12 per 10 U/mL, 95% CI 1.04–1.21), and CA19-9 (aOR 1.16 per 10 U/mL, 95% CI 1.06–1.27) were associated with malignant pathology. Endometrial thickness showed evidence of nonlinearity (P = 0.030). Adding CA125 and CA19-9 to a model including age and endometrial thickness increased the apparent AUC from 0.744 to 0.781. BMI and conventional lipid-related measures showed limited discriminatory associations. Conclusions: Age, endometrial thickness, and selected tumor markers were associated with malignant pathology in this pathology-selected PMB cohort. The incremental discrimination provided by tumor markers was modest, and the findings require external validation before clinical application.

Research Square
Jiangnan University (CN), Nanjing Medical University (CN)
Jiangnan University
Good health and well-being
Endometrial and Cervical Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon